

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.18772088 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.96834088 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.96834088 |
| 4 | * modulation by symbiont of host immune response (GO:0052553) | 5.91029881 |
| 5 | * positive regulation by symbiont of host defense response (GO:0052509) | 5.91029881 |
| 6 | * modulation by symbiont of host defense response (GO:0052031) | 5.91029881 |
| 7 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.91029881 |
| 8 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.91029881 |
| 9 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.91029881 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.13216710 |
| 11 | detection of other organism (GO:0098543) | 5.03182873 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.87318221 |
| 13 | response to peptidoglycan (GO:0032494) | 4.69874613 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.61620143 |
| 15 | * macrophage activation involved in immune response (GO:0002281) | 4.60884010 |
| 16 | * detection of external biotic stimulus (GO:0098581) | 4.59324061 |
| 17 | detection of bacterium (GO:0016045) | 4.49882910 |
| 18 | respiratory burst (GO:0045730) | 4.44648511 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.44447743 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44378990 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44378990 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.41290296 |
| 23 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.37026262 |
| 24 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.35035482 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.27283615 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22797760 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17229429 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.15431676 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.14690312 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 4.10947785 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.08976580 |
| 32 | response to interleukin-15 (GO:0070672) | 4.01958294 |
| 33 | * detection of biotic stimulus (GO:0009595) | 3.97285202 |
| 34 | leukocyte aggregation (GO:0070486) | 3.92498933 |
| 35 | granulocyte activation (GO:0036230) | 3.86545630 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.86490191 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.81037354 |
| 38 | neutrophil activation (GO:0042119) | 3.76615482 |
| 39 | * response to host immune response (GO:0052572) | 3.74103224 |
| 40 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.74103224 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73530323 |
| 42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.70719828 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.70329513 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.63981562 |
| 45 | * myeloid cell activation involved in immune response (GO:0002275) | 3.60297523 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.57655680 |
| 47 | cellular extravasation (GO:0045123) | 3.57298517 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56572895 |
| 49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.54803648 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.54526092 |
| 51 | negative regulation of mast cell activation (GO:0033004) | 3.54331414 |
| 52 | * microglial cell activation (GO:0001774) | 3.50573756 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.50167881 |
| 54 | B cell mediated immunity (GO:0019724) | 3.48932540 |
| 55 | superoxide anion generation (GO:0042554) | 3.47598529 |
| 56 | positive regulation of heat generation (GO:0031652) | 3.42307621 |
| 57 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.42051055 |
| 58 | positive regulation of macrophage differentiation (GO:0045651) | 3.41768751 |
| 59 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.41029429 |
| 60 | * response to host (GO:0075136) | 3.41029429 |
| 61 | * response to host defenses (GO:0052200) | 3.41029429 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.39607026 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.39607026 |
| 64 | response to type I interferon (GO:0034340) | 3.38881428 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.37973853 |
| 66 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.37796609 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35773646 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.35012873 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34900902 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 3.34068607 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.33946909 |
| 72 | * macrophage activation (GO:0042116) | 3.30774708 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29867040 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29335393 |
| 75 | negative thymic T cell selection (GO:0045060) | 3.28911254 |
| 76 | regulation of B cell differentiation (GO:0045577) | 3.28438851 |
| 77 | regulation of fever generation (GO:0031620) | 3.27870474 |
| 78 | T cell migration (GO:0072678) | 3.25217658 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23193347 |
| 80 | defense response to protozoan (GO:0042832) | 3.22568929 |
| 81 | negative T cell selection (GO:0043383) | 3.20570939 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 3.20131496 |
| 83 | positive thymic T cell selection (GO:0045059) | 3.17186030 |
| 84 | * detection of molecule of bacterial origin (GO:0032490) | 3.14235657 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11855052 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 3.11855052 |
| 87 | dendritic cell migration (GO:0036336) | 3.11452391 |
| 88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09546978 |
| 89 | reactive oxygen species biosynthetic process (GO:1903409) | 3.08659213 |
| 90 | B cell receptor signaling pathway (GO:0050853) | 3.07425700 |
| 91 | cellular response to zinc ion (GO:0071294) | 3.06830334 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.05397483 |
| 93 | positive regulation of interferon-beta production (GO:0032728) | 3.02867998 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02403204 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01168065 |
| 96 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.99847227 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.97544101 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.97544101 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97479241 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97181054 |
| 101 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.96302289 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95955509 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.95846356 |
| 104 | germinal center formation (GO:0002467) | 2.94622771 |
| 105 | response to protozoan (GO:0001562) | 2.93732802 |
| 106 | * myeloid leukocyte activation (GO:0002274) | 2.92079264 |
| 107 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91983900 |
| 108 | regulation of tolerance induction (GO:0002643) | 2.91246140 |
| 109 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90883915 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.90632391 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.90177544 |
| 112 | mast cell activation (GO:0045576) | 2.89092510 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88520117 |
| 114 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.88462923 |
| 115 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.87760080 |
| 116 | positive regulation of humoral immune response (GO:0002922) | 2.87675596 |
| 117 | lipopolysaccharide metabolic process (GO:0008653) | 2.87629251 |
| 118 | positive regulation of chemokine production (GO:0032722) | 2.86310587 |
| 119 | leukocyte cell-cell adhesion (GO:0007159) | 2.85916153 |
| 120 | neutrophil mediated immunity (GO:0002446) | 2.84458262 |
| 121 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.82657873 |
| 122 | negative regulation of phagocytosis (GO:0050765) | 2.82269216 |
| 123 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81986467 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80483274 |
| 125 | regulation of leukocyte degranulation (GO:0043300) | 2.80004397 |
| 126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79622592 |
| 127 | regulation of podosome assembly (GO:0071801) | 2.79480986 |
| 128 | * positive regulation of cytokine biosynthetic process (GO:0042108) | 2.78371114 |
| 129 | neutrophil chemotaxis (GO:0030593) | 2.77629350 |
| 130 | leukocyte degranulation (GO:0043299) | 2.76950505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.78010451 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.34464849 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.53190615 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17918617 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.16359389 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.99524469 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.80330913 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.79705964 |
| 9 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72383557 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.64268268 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.58702391 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58413388 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.13795230 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09101155 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00931669 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87313983 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77422738 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60538253 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.50518516 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47336384 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45454577 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36525714 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26519522 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14162054 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.11350200 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02105996 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00259182 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99952068 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99055608 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95577622 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.85971545 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84621045 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.84138299 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83015876 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82238848 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79628783 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73697996 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73445965 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72536206 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68476359 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68364445 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66991217 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64639946 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58922119 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57356353 |
| 46 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56175486 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53475562 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46605509 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46604457 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42034255 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39948719 |
| 52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36483837 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36388634 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35006338 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.34924475 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30854353 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30752421 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30576009 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28585208 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26254004 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24689435 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24258603 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22548394 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20631503 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17062495 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14118236 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13325477 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12923025 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11289007 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10859378 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09324591 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07013678 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05455322 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03327419 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.01808836 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01752146 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97505111 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95258627 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94450266 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94097838 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93295231 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92007336 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91702483 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89821052 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89126368 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89114050 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86748715 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86473173 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81605384 |
| 90 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80886535 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80740741 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80679338 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80563265 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80425757 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76857406 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76800382 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76767127 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76210803 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75137571 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74208194 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73403171 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71047834 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.70618159 |
| 104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69376203 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.68805120 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68765610 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66265254 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65495419 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 0.62997911 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.60033553 |
| 111 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.58950537 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58166297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.43695004 |
| 2 | MP0009785_altered_susceptibility_to | 3.66267495 |
| 3 | MP0003436_decreased_susceptibility_to | 3.64175435 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.25882437 |
| 5 | MP0003303_peritoneal_inflammation | 3.25356958 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.03684459 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.03258057 |
| 8 | MP0003724_increased_susceptibility_to | 3.02583416 |
| 9 | MP0005025_abnormal_response_to | 2.99332394 |
| 10 | MP0005671_abnormal_response_to | 2.98328710 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.93007205 |
| 12 | MP0005387_immune_system_phenotype | 2.88622200 |
| 13 | MP0001790_abnormal_immune_system | 2.88622200 |
| 14 | MP0001800_abnormal_humoral_immune | 2.82061413 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.80746544 |
| 16 | MP0006082_CNS_inflammation | 2.78222440 |
| 17 | MP0000685_abnormal_immune_system | 2.71766187 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.63494321 |
| 19 | * MP0002723_abnormal_immune_serum | 2.61638577 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.48044311 |
| 21 | * MP0001819_abnormal_immune_cell | 2.44474221 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.43870268 |
| 23 | MP0005451_abnormal_body_composition | 2.27946703 |
| 24 | MP0008260_abnormal_autophagy | 2.24285021 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.07088561 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05363676 |
| 27 | MP0004510_myositis | 2.02063481 |
| 28 | MP0001853_heart_inflammation | 1.99488980 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.98018628 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.95687997 |
| 31 | MP0009764_decreased_sensitivity_to | 1.89710528 |
| 32 | MP0002398_abnormal_bone_marrow | 1.88539197 |
| 33 | MP0000716_abnormal_immune_system | 1.86494849 |
| 34 | MP0004947_skin_inflammation | 1.77710820 |
| 35 | MP0009278_abnormal_bone_marrow | 1.72560017 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.70222316 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.67459681 |
| 38 | MP0008469_abnormal_protein_level | 1.65833566 |
| 39 | MP0004381_abnormal_hair_follicle | 1.64589174 |
| 40 | MP0009840_abnormal_foam_cell | 1.61313477 |
| 41 | MP0000343_altered_response_to | 1.61094771 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.58262266 |
| 43 | MP0002429_abnormal_blood_cell | 1.55126982 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.54710192 |
| 45 | MP0002006_tumorigenesis | 1.54077733 |
| 46 | MP0002722_abnormal_immune_system | 1.51331185 |
| 47 | MP0003075_altered_response_to | 1.47766625 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.45811659 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.45811659 |
| 50 | MP0003448_altered_tumor_morphology | 1.45696311 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.38861356 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.34687723 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.32236839 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.31321257 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.31208027 |
| 56 | MP0000858_altered_metastatic_potential | 1.30129486 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.22309989 |
| 58 | MP0002933_joint_inflammation | 1.18940863 |
| 59 | MP0005310_abnormal_salivary_gland | 1.18303955 |
| 60 | MP0005166_decreased_susceptibility_to | 1.17644742 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.17225368 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.16108484 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.07728402 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.06096988 |
| 65 | MP0005390_skeleton_phenotype | 0.99063142 |
| 66 | MP0008057_abnormal_DNA_replication | 0.98944943 |
| 67 | MP0003186_abnormal_redox_activity | 0.98486152 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 0.97799119 |
| 69 | MP0009763_increased_sensitivity_to | 0.97400559 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.97373291 |
| 71 | MP0003828_pulmonary_edema | 0.93968289 |
| 72 | MP0010307_abnormal_tumor_latency | 0.92870718 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.91242947 |
| 74 | MP0005164_abnormal_response_to | 0.91153529 |
| 75 | MP0001851_eye_inflammation | 0.90798904 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90688691 |
| 77 | MP0000703_abnormal_thymus_morphology | 0.89949983 |
| 78 | MP0000604_amyloidosis | 0.89850530 |
| 79 | MP0000249_abnormal_blood_vessel | 0.87328213 |
| 80 | MP0003690_abnormal_glial_cell | 0.83923307 |
| 81 | MP0001873_stomach_inflammation | 0.82929368 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.82049148 |
| 83 | MP0006054_spinal_hemorrhage | 0.78888956 |
| 84 | MP0001663_abnormal_digestive_system | 0.73559682 |
| 85 | MP0000371_diluted_coat_color | 0.72733063 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.71993975 |
| 87 | MP0003795_abnormal_bone_structure | 0.71938627 |
| 88 | MP0004130_abnormal_muscle_cell | 0.70922916 |
| 89 | MP0003045_fibrosis | 0.70503153 |
| 90 | MP0003279_aneurysm | 0.69666536 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.69291708 |
| 92 | MP0005023_abnormal_wound_healing | 0.69273289 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.69085563 |
| 94 | MP0003866_abnormal_defecation | 0.68083761 |
| 95 | MP0000490_abnormal_crypts_of | 0.67410058 |
| 96 | MP0001958_emphysema | 0.66588905 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.65821583 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.65326219 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.65260537 |
| 100 | MP0008874_decreased_physiological_sensi | 0.63825490 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.63595741 |
| 102 | MP0004883_abnormal_blood_vessel | 0.59822530 |
| 103 | MP0003252_abnormal_bile_duct | 0.59471076 |
| 104 | MP0003787_abnormal_imprinting | 0.58792057 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.58278033 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.57997879 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.57537960 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.56681533 |
| 109 | MP0008873_increased_physiological_sensi | 0.56642281 |
| 110 | MP0008004_abnormal_stomach_pH | 0.56635869 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.56489417 |
| 112 | MP0000609_abnormal_liver_physiology | 0.56416170 |
| 113 | MP0003091_abnormal_cell_migration | 0.56346096 |
| 114 | MP0002928_abnormal_bile_duct | 0.55191951 |
| 115 | MP0004484_altered_response_of | 0.54441963 |
| 116 | MP0002132_abnormal_respiratory_system | 0.54358442 |
| 117 | MP0005388_respiratory_system_phenotype | 0.54281527 |
| 118 | MP0002133_abnormal_respiratory_system | 0.54281527 |
| 119 | MP0003195_calcinosis | 0.53909136 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.53615086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.98869759 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.33241640 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.31576127 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.46159299 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.06227599 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.75027570 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.61007322 |
| 8 | Myositis (HP:0100614) | 4.54200199 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.39230568 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.33521281 |
| 11 | Orchitis (HP:0100796) | 4.22894747 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.15690115 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.04094310 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.00311028 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.99056293 |
| 16 | Optic neuritis (HP:0100653) | 3.99056293 |
| 17 | Recurrent skin infections (HP:0001581) | 3.90933044 |
| 18 | Stomatitis (HP:0010280) | 3.90373035 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.73729480 |
| 20 | T lymphocytopenia (HP:0005403) | 3.69959876 |
| 21 | Gingivitis (HP:0000230) | 3.69859153 |
| 22 | Cellulitis (HP:0100658) | 3.65740515 |
| 23 | Obstructive lung disease (HP:0006536) | 3.58576841 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.58576841 |
| 25 | Vasculitis (HP:0002633) | 3.50224416 |
| 26 | Chronic otitis media (HP:0000389) | 3.41502113 |
| 27 | Recurrent viral infections (HP:0004429) | 3.40972941 |
| 28 | Periodontitis (HP:0000704) | 3.31542670 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.14780872 |
| 30 | Meningitis (HP:0001287) | 3.12859261 |
| 31 | Pustule (HP:0200039) | 3.11606948 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.09125636 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05103951 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05103951 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05103951 |
| 36 | Peritonitis (HP:0002586) | 3.03033020 |
| 37 | Increased IgE level (HP:0003212) | 3.00105530 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.97769215 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.90585274 |
| 40 | Gingival bleeding (HP:0000225) | 2.79637170 |
| 41 | Leukocytosis (HP:0001974) | 2.79452641 |
| 42 | Osteomyelitis (HP:0002754) | 2.76706039 |
| 43 | Urticaria (HP:0001025) | 2.76680512 |
| 44 | Recurrent pneumonia (HP:0006532) | 2.75599554 |
| 45 | Petechiae (HP:0000967) | 2.74639420 |
| 46 | Glomerulonephritis (HP:0000099) | 2.73994649 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.71514459 |
| 48 | Anorexia (HP:0002039) | 2.68835006 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66545922 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66545922 |
| 51 | Hypochromic anemia (HP:0001931) | 2.66498071 |
| 52 | Increased IgM level (HP:0003496) | 2.64375539 |
| 53 | Basal ganglia calcification (HP:0002135) | 2.64357713 |
| 54 | Arterial thrombosis (HP:0004420) | 2.64218424 |
| 55 | Pulmonary embolism (HP:0002204) | 2.63382505 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.61028704 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.57582622 |
| 58 | Episodic fever (HP:0001954) | 2.55439442 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.54541621 |
| 60 | Prostate neoplasm (HP:0100787) | 2.50556327 |
| 61 | Viral hepatitis (HP:0006562) | 2.50138594 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.49606915 |
| 63 | Abnormality of the peritoneum (HP:0002585) | 2.46680700 |
| 64 | Epistaxis (HP:0000421) | 2.46270851 |
| 65 | Fatigue (HP:0012378) | 2.44972642 |
| 66 | Axonal loss (HP:0003447) | 2.44801400 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.43347438 |
| 68 | Granulocytopenia (HP:0001913) | 2.43226017 |
| 69 | Hematochezia (HP:0002573) | 2.43039128 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42837219 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.41954311 |
| 72 | Gangrene (HP:0100758) | 2.41923338 |
| 73 | Recurrent bronchitis (HP:0002837) | 2.38117953 |
| 74 | Thick nail (HP:0001805) | 2.36033864 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.34815906 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.33556075 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.33127623 |
| 78 | Hemoptysis (HP:0002105) | 2.32995876 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.32128268 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.30523872 |
| 81 | Tetraparesis (HP:0002273) | 2.29076161 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.28379045 |
| 83 | Subacute progressive viral hepatitis (HP:0006572) | 2.24025137 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.23628943 |
| 85 | Amyloidosis (HP:0011034) | 2.23289998 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.22671110 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.22613810 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.21487548 |
| 89 | Thrombocytosis (HP:0001894) | 2.20903054 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.20037721 |
| 91 | Glomerulopathy (HP:0100820) | 2.19748620 |
| 92 | Myocardial infarction (HP:0001658) | 2.19473996 |
| 93 | Colitis (HP:0002583) | 2.19271858 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.18637308 |
| 95 | Disinhibition (HP:0000734) | 2.17871957 |
| 96 | Emphysema (HP:0002097) | 2.16449406 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15762821 |
| 98 | Lymphopenia (HP:0001888) | 2.15466737 |
| 99 | IgM deficiency (HP:0002850) | 2.15069160 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14868871 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.14416835 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14416835 |
| 103 | Microcytic anemia (HP:0001935) | 2.14055128 |
| 104 | Abnormality of the pleura (HP:0002103) | 2.13587615 |
| 105 | Cheilitis (HP:0100825) | 2.12984607 |
| 106 | Purpura (HP:0000979) | 2.12689913 |
| 107 | Eosinophilia (HP:0001880) | 2.11859228 |
| 108 | Nasal polyposis (HP:0100582) | 2.11731247 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 2.11476742 |
| 110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11426511 |
| 111 | Recurrent sinusitis (HP:0011108) | 2.10022651 |
| 112 | Agnosia (HP:0010524) | 2.09780922 |
| 113 | J-shaped sella turcica (HP:0002680) | 2.09087683 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08226586 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08226586 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08226586 |
| 117 | Chest pain (HP:0100749) | 2.07944861 |
| 118 | Encephalitis (HP:0002383) | 2.07296853 |
| 119 | Skin ulcer (HP:0200042) | 2.06531975 |
| 120 | Abnormality of T cells (HP:0002843) | 2.05566122 |
| 121 | Sepsis (HP:0100806) | 2.05280159 |
| 122 | Restrictive lung disease (HP:0002091) | 2.03422767 |
| 123 | Vertigo (HP:0002321) | 2.03418536 |
| 124 | Keratitis (HP:0000491) | 2.01360137 |
| 125 | Acute hepatic failure (HP:0006554) | 1.98711075 |
| 126 | Skin rash (HP:0000988) | 1.87218419 |
| 127 | Premature loss of primary teeth (HP:0006323) | 1.86547967 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.85333972 |
| 129 | Abnormality of eosinophils (HP:0001879) | 1.85154659 |
| 130 | Verrucae (HP:0200043) | 1.84455975 |
| 131 | Papilloma (HP:0012740) | 1.84455975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.99984639 |
| 2 | MAP3K14 | 3.81152418 |
| 3 | IRAK4 | 3.26137852 |
| 4 | TBK1 | 3.20988075 |
| 5 | TXK | 3.18278786 |
| 6 | BLK | 3.01587318 |
| 7 | RIPK4 | 2.96871058 |
| 8 | TYK2 | 2.77920780 |
| 9 | IRAK3 | 2.68330969 |
| 10 | IKBKE | 2.59405874 |
| 11 | ERN1 | 2.56378423 |
| 12 | KIT | 2.41964121 |
| 13 | ZAP70 | 2.15788858 |
| 14 | JAK3 | 2.15693660 |
| 15 | TGFBR2 | 2.11084034 |
| 16 | STK16 | 2.10464186 |
| 17 | CSK | 1.98482330 |
| 18 | BTK | 1.97261543 |
| 19 | IKBKB | 1.97100802 |
| 20 | RIPK1 | 1.95162461 |
| 21 | PRPF4B | 1.85219881 |
| 22 | CSF1R | 1.83759095 |
| 23 | TAOK3 | 1.69181374 |
| 24 | STK10 | 1.68893380 |
| 25 | SYK | 1.66888020 |
| 26 | JAK1 | 1.65895285 |
| 27 | HCK | 1.56307525 |
| 28 | TEC | 1.53265688 |
| 29 | LYN | 1.49821128 |
| 30 | MST4 | 1.48919814 |
| 31 | FES | 1.45962077 |
| 32 | KSR2 | 1.42082635 |
| 33 | MAP3K3 | 1.36279648 |
| 34 | EPHB1 | 1.33491814 |
| 35 | LCK | 1.32551614 |
| 36 | MAP3K1 | 1.31981526 |
| 37 | MAP3K2 | 1.30676287 |
| 38 | CLK1 | 1.27025582 |
| 39 | TAOK1 | 1.25735904 |
| 40 | RPS6KA4 | 1.24391230 |
| 41 | ITK | 1.24285978 |
| 42 | CHUK | 1.21293726 |
| 43 | IRAK2 | 1.19367780 |
| 44 | PBK | 1.18278197 |
| 45 | PIM2 | 1.10595976 |
| 46 | MATK | 1.10321178 |
| 47 | FLT3 | 1.08137962 |
| 48 | MAP3K13 | 1.04935640 |
| 49 | PIM1 | 0.99031997 |
| 50 | MAP2K3 | 0.96903320 |
| 51 | FGR | 0.90149089 |
| 52 | JAK2 | 0.89249527 |
| 53 | TGFBR1 | 0.89227880 |
| 54 | NEK9 | 0.89150770 |
| 55 | MARK2 | 0.87528074 |
| 56 | FGFR4 | 0.87323967 |
| 57 | CDK19 | 0.87266213 |
| 58 | PTK2B | 0.87070300 |
| 59 | MAP3K6 | 0.86613571 |
| 60 | PDK1 | 0.86461338 |
| 61 | EIF2AK2 | 0.85610487 |
| 62 | GRK6 | 0.85371479 |
| 63 | STK4 | 0.84959893 |
| 64 | MARK3 | 0.81537665 |
| 65 | GRK7 | 0.80684252 |
| 66 | TRPM7 | 0.78612363 |
| 67 | NME2 | 0.76532816 |
| 68 | FGFR3 | 0.72874289 |
| 69 | ACVR1B | 0.72863623 |
| 70 | WNK1 | 0.69482876 |
| 71 | RAF1 | 0.68983769 |
| 72 | PDPK1 | 0.68787783 |
| 73 | MAP2K4 | 0.68160199 |
| 74 | LRRK2 | 0.67149185 |
| 75 | SGK3 | 0.66790743 |
| 76 | KSR1 | 0.64617952 |
| 77 | SIK3 | 0.64246272 |
| 78 | CAMKK2 | 0.63202156 |
| 79 | EGFR | 0.61715585 |
| 80 | TNK2 | 0.60690357 |
| 81 | SGK2 | 0.59901171 |
| 82 | MAP3K7 | 0.59800642 |
| 83 | CDC42BPA | 0.58906054 |
| 84 | PRKCD | 0.58834970 |
| 85 | STK11 | 0.58617473 |
| 86 | PRKD2 | 0.58364396 |
| 87 | PIK3CG | 0.56477597 |
| 88 | PKN2 | 0.55717391 |
| 89 | MAP3K10 | 0.51950826 |
| 90 | SIK2 | 0.50431275 |
| 91 | MAPK12 | 0.50302153 |
| 92 | BMX | 0.49723033 |
| 93 | BMPR1B | 0.49714390 |
| 94 | CAMKK1 | 0.48134172 |
| 95 | ABL1 | 0.47996944 |
| 96 | MAPK7 | 0.47030244 |
| 97 | IRAK1 | 0.46579625 |
| 98 | YES1 | 0.46559631 |
| 99 | MAP3K11 | 0.44956261 |
| 100 | MUSK | 0.44932099 |
| 101 | RET | 0.44497748 |
| 102 | NLK | 0.44219435 |
| 103 | RPS6KA6 | 0.43869411 |
| 104 | HIPK2 | 0.43577884 |
| 105 | BMPR2 | 0.42676672 |
| 106 | CAMK1D | 0.42527327 |
| 107 | MAPKAPK2 | 0.42443734 |
| 108 | MAP2K6 | 0.41661065 |
| 109 | PRKG2 | 0.41518371 |
| 110 | PRKCQ | 0.41268954 |
| 111 | EPHA3 | 0.41082275 |
| 112 | TAOK2 | 0.40405245 |
| 113 | FRK | 0.40060615 |
| 114 | DYRK1B | 0.39896119 |
| 115 | TTN | 0.39355823 |
| 116 | MAPK4 | 0.39286369 |
| 117 | TRIB3 | 0.38051906 |
| 118 | IGF1R | 0.37205665 |
| 119 | DAPK2 | 0.36252062 |
| 120 | CCNB1 | 0.35015125 |
| 121 | KDR | 0.33826865 |
| 122 | PAK4 | 0.33762135 |
| 123 | ADRBK2 | 0.33433518 |
| 124 | RPS6KL1 | 0.31424980 |
| 125 | RPS6KC1 | 0.31424980 |
| 126 | MOS | 0.30990815 |
| 127 | ABL2 | 0.30449842 |
| 128 | PTK6 | 0.30341462 |
| 129 | DYRK3 | 0.29593230 |
| 130 | FYN | 0.28697465 |
| 131 | INSR | 0.27892713 |
| 132 | MAPK11 | 0.27635923 |
| 133 | EIF2AK1 | 0.24983944 |
| 134 | CDK12 | 0.24194539 |
| 135 | STK3 | 0.23477149 |
| 136 | MAP3K12 | 0.23368070 |
| 137 | MAP3K5 | 0.22059332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.52508194 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.44907645 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.98652180 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83315120 |
| 5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.72614812 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54194845 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.41350054 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38371745 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.34520133 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.31704787 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19104265 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.16861818 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16301150 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.14541149 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06909284 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03986154 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03086902 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.00538900 |
| 19 | * Tuberculosis_Homo sapiens_hsa05152 | 1.99015403 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94072256 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89842978 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88177148 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.87704525 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77186028 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75705654 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75320806 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.66108182 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64532904 |
| 29 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64060489 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61968536 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57470605 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56898248 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54304640 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53857687 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.50065571 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43026218 |
| 37 | * Phagosome_Homo sapiens_hsa04145 | 1.41465637 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38521737 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37425621 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.32618621 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31963727 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.31858327 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27960124 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.11365484 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10051652 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99832014 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99824440 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98273629 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97006003 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.96052460 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93075452 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90298154 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89004643 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87589654 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.87366613 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85967811 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84154420 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81745428 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78915551 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73730176 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70442962 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70059042 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68970581 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.68833472 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68463149 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67354862 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67164070 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66217312 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65128976 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63463465 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62894535 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61585580 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60113993 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57806731 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57375840 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.57054057 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55774942 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55266824 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54643792 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52287377 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51890700 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51221161 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49695677 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49217078 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49174925 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.48228327 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47973408 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45982708 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45610173 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45566121 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.45158441 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44923315 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43709306 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43435127 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42486666 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41289562 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41196853 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39822644 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.38696852 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36911103 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36859317 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36618603 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36589536 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34934479 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29367065 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29072634 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.26629852 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.23737124 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22640748 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21408664 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20484935 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16959481 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16845474 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16027865 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15529667 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15274146 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15252729 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.13664827 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13641368 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12615743 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10586564 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10214090 |

